Food Study of Ondansetron Orally Disintegrating Tablets 8 mg to Zofran ODT® Tablets 8 mg

NCT00648804 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Ondansetron Orally Disintegrating Tablets 8 mg
DRUG: Zofran ODT® Tablets 8 mg

Sponsor

Mylan Pharmaceuticals Inc